We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
+31.52%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$874M
AUM Growth
-$25.1M
Cap. Flow
-$193M
Cap. Flow %
-22.04%
Top 10 Hldgs %
51.18%
Holding
205
New
56
Increased
8
Reduced
44
Closed
39

Top Buys

Rank Stock Value
1
ANGI icon
Angi Inc
ANGI
+$19.4M
2
PPLI
People Inc
PPLI
+$18.5M
3
W icon
Wayfair
W
+$16.8M
4
CPS icon
Cooper-Standard Automotive
CPS
+$11.3M
5
CDLX icon
Cardlytics
CDLX
+$9.78M

Sector Composition

Rank Sector Weight
1 Healthcare 23.11%
2 Consumer Discretionary 22.28%
3 Communication Services 10.57%
4 Financials 4.06%
5 Materials 2.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALDX icon
26
Aldeyra Therapeutics
ALDX
$97.1M
$10M 1.15%
1,727,700
-622,300
-26% -$3.59M
ENVA icon
27
Enova International
ENVA
$6.09B
$9.74M 1.11%
405,000
-490,000
-55% -$11M
SNDX icon
28
Syndax Pharmaceuticals
SNDX
$1.7B
$8.12M 0.93%
925,000
-246,648
-21% -$1.81M
MGTX icon
29
MeiraGTx Holdings
MGTX
$1.08B
$8.11M 0.93%
405,000
+5,000
+1% +$85.6K
GSAT icon
30
Globalstar
GSAT
$10.1B
$8M 0.91%
1,027,719
CRESY
31
Cresud
CRESY
$806M
$6.78M 0.77%
1,001,605
-1
-0% -$5
HOME
32
DELISTED
At Home Group Inc.
HOME
$6.6M 0.75%
1,200,000
-1,250,000
-51% -$10.2M
RDHL
33
Redhill Biopharma
RDHL
$4.15M
$6.28M 0.72%
1,035
-2,441
-70% -$15.6M
IRS
34
IRSA Inversiones y Representaciones
IRS
$1.31B
$6.27M 0.72%
878,472
-18,448
-2% -$106K
FENC icon
35
Fennec Pharmaceuticals
FENC
$335M
$6.17M 0.71%
950,000
-21,351
-2% -$115K
OMF icon
36
OneMain Financial
OMF
$7.27B
$6.11M 0.7%
+145,000
New +$5.86M
INTC icon
37
PUT
Intel
INTC
$413B
$5.99M 0.68%
100,000
KG
38
Kestrel Group
KG
$66.1M
$5.91M 0.68%
393,848
TRVG
39
trivago
TRVG
$385M
$5.65M 0.65%
431,340
-192,927
-31% -$2.94M
INSE icon
40
Inspired Entertainment
INSE
$183M
$5.41M 0.62%
801,824
ERII icon
41
Energy Recovery
ERII
$420M
$5.29M 0.6%
540,000
-430,000
-44% -$3.96M
HCC icon
42
Warrior Met Coal
HCC
$4.17B
$5.18M 0.59%
245,000
CUE icon
43
Cue Biopharma
CUE
$118M
$5.08M 0.58%
10,667
+667
+7% +$210K
TWNKW
44
DELISTED
Hostess Brands, Inc. Warrants
TWNKW
$4.96M 0.57%
2,520,000
NMCI
45
DELISTED
Navios Maritime Containers L.P. Common Units
NMCI
$4.8M 0.55%
2,235,000
GLMD icon
46
Galmed Pharmaceuticals
GLMD
$4.62M
$4.62M 0.53%
4,444
-3,091
-41% -$2.66M
TGTX icon
47
TG Therapeutics
TGTX
$8.19B
$4.42M 0.51%
398,271
-1,729
-0.4% -$13.1K
FATE icon
48
Fate Therapeutics
FATE
$275M
$4.4M 0.5%
225,000
DHT icon
49
DHT Holdings
DHT
$2.99B
$4.26M 0.49%
515,000
OTIC
50
DELISTED
Otonomy, Inc.
OTIC
$4.21M 0.48%
1,100,000

Similar funds

683 Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, 683 Capital Management held 205 positions worth $874M, down 2.8% from $899M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

683 Capital Management withdrew a net $193M in Q4 2019, closing 39 positions and reducing 44 holdings. Its most notable exit was NII Holdings, Inc. Common Stock, an estimated $25.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, 683 Capital Management opened a new position in Angi Inc worth $22M.

  • 683 Capital Management's largest Q4 2019 buy was Angi Inc: 260,000 shares worth $22M.
  • 683 Capital Management added most to Cardlytics in Q4 2019, an estimated $9.78M increase.
  • 683 Capital Management's biggest Q4 2019 reduction was Carvana, cutting an estimated $37.7M.
  • 683 Capital Management fully exited NII Holdings, Inc. Common Stock in Q4 2019, selling an estimated $25.8M.
  • 683 Capital Management's ten largest holdings make up 51% of its $874M portfolio in Q4 2019.
  • 683 Capital Management opened 56 new positions and closed 39 in Q4 2019.
  • 683 Capital Management's portfolio value fell 2.8% quarter-over-quarter to $874M.

Based on 683 Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.